Randomized Controlled Trial
Copyright ©The Author(s) 2019.
World J Orthop. Sep 18, 2019; 10(9): 310-326
Published online Sep 18, 2019. doi: 10.5312/wjo.v10.i9.310
Figure 1
Figure 1 CONSORT flowchart.
Figure 2
Figure 2 Comparison of the pain score indices between the three intervention groups at baseline and subsequent follow-ups. A: Comparison of the percentage change in pain from baseline to wk 4 (1st follow-up), wk 8 (2nd follow-up) and wk 12 (3rd follow-up) between the three groups; B: Comparison of the mean pain scores at baseline and subsequent follow-ups between the three groups. Negative shows a benefit from pre-treatment values.
Figure 3
Figure 3 Comparison of the stiffness score indices between the three intervention groups at baseline and subsequent follow-ups. A: Comparison of the percentage change in stiffness from baseline to wk 4 (1st follow-up), wk 8 (2nd follow-up), and wk 12 (3rd follow-up) between the three groups; B: Comparison of the mean stiffness scores at baseline and subsequent follow-ups between the three groups. Negative shows a benefit from pre-treatment values.
Figure 4
Figure 4 Comparison of the physical function score indices between the three intervention groups at baseline and subsequent follow-ups. A: Comparison of the percentage change in physical function from baseline to wk 4 (1st follow-up), wk 8 (2nd follow-up), and wk 12 (3rd follow-up) between the three groups; B: Comparison of the mean physical function scores at baseline and subsequent follow-ups between the three groups. Negative shows a benefit from pre-treatment values.
Figure 5
Figure 5 Comparison of the total Western Ontario and McMaster Universities Arthritis Index scores between the three intervention groups at baseline and subsequent follow-ups. A: Comparison of the percentage change in total scores from baseline to wk 4 (1st follow-up), wk 8 (2nd follow-up), and wk 12 (3rd follow-up) between the three groups; B: Comparison of the mean total scores at baseline and subsequent follow-ups between the three groups. Negative shows a benefit from pre-treatment values.
Figure 6
Figure 6 Comparison of the Visual Analogue Scale pain scores between the three intervention groups at baseline and subsequent follow-ups. A: Comparison of the percentage change in scores from baseline to wk 4 (1st follow-up), wk 8 (2nd follow-up), and wk 12 (3rd follow-up) between the three groups; B: Comparison of the mean scores at baseline and subsequent follow-ups between the three groups. Negative shows a benefit from pre-treatment values.